Literature DB >> 21632767

A single amino acid in nonstructural protein NS4B confers virulence to dengue virus in AG129 mice through enhancement of viral RNA synthesis.

Dixon Grant1, Grace K Tan, Min Qing, Jowin K W Ng, Andy Yip, Gang Zou, Xuping Xie, Zhiming Yuan, Mark J Schreiber, Wouter Schul, Pei-Yong Shi, Sylvie Alonso.   

Abstract

Dengue (DEN) is a mosquito-borne viral disease that has become an increasing economic and health burden for the tropical and subtropical world. The lack of an appropriate animal model of DEN has greatly impeded the study of its pathogenesis and the development of vaccines/antivirals. We recently reported a DEN virus 2 (DENV-2) strain (D2Y98P) that lethally infects immunocompromised AG129 mice, resulting in organ damage or dysfunction and increased vascular permeability, hallmarks of severe DEN in patients (G. K. Tan et al., PLoS Negl. Trop. Dis. 4:e672, 2010). Here we report the identification of one critical virulence determinant of strain D2Y98P. By mutagenesis, we showed that a Phe-to-Leu alteration at amino acid position 52 in nonstructural protein NS4B completely abolished the pathogenicity of the D2Y98P virus, as evidenced by a lack of lethality and the absence of histological signs of disease, which correlated with reduced viral titers and intact vascular permeability. Conversely, a Leu-to-Phe alteration at position 52 of NS4B in nonvirulent DENV-2 strain TSV01 led to 80% lethality and increased viremia. The NS4B(Phe52) viruses displayed enhanced RNA synthesis in mammalian cells but not in mosquito cells. The increased viral RNA synthesis was independent of the ability of NS4B to interfere with the host type I interferon response. Overall, our results demonstrate that Phe at position 52 in NS4B confers virulence in mice on two independent DENV-2 strains through enhancement of viral RNA synthesis. In addition to providing further insights into the functional role of NS4B protein, our findings further support a direct relationship between viral loads and DEN pathogenesis in vivo, consistent with observations in DEN patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21632767      PMCID: PMC3147917          DOI: 10.1128/JVI.00665-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Molecular evolution, distribution and genetic relationship among the dengue 2 viruses isolated from different clinical severity.

Authors:  B D Pandey; K Morita; F Hasebe; M C Parquet; A Igarashi
Journal:  Southeast Asian J Trop Med Public Health       Date:  2000-06       Impact factor: 0.267

2.  Structure of dengue virus: implications for flavivirus organization, maturation, and fusion.

Authors:  Richard J Kuhn; Wei Zhang; Michael G Rossmann; Sergei V Pletnev; Jeroen Corver; Edith Lenches; Christopher T Jones; Suchetana Mukhopadhyay; Paul R Chipman; Ellen G Strauss; Timothy S Baker; James H Strauss
Journal:  Cell       Date:  2002-03-08       Impact factor: 41.582

3.  Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses.

Authors:  Jorge L Muñoz-Jordán; Maudry Laurent-Rolle; Joseph Ashour; Luis Martínez-Sobrido; Mundrigi Ashok; W Ian Lipkin; Adolfo García-Sastre
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist.

Authors:  Sonja M Best; Keely L Morris; Jeffrey G Shannon; Shelly J Robertson; Dana N Mitzel; Gregory S Park; Elena Boer; James B Wolfinbarger; Marshall E Bloom
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

5.  Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever.

Authors:  D M Watts; K R Porter; P Putvatana; B Vasquez; C Calampa; C G Hayes; S B Halstead
Journal:  Lancet       Date:  1999-10-23       Impact factor: 79.321

6.  Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins.

Authors:  Wen Jun Liu; Xiang Ju Wang; Vladislav V Mokhonov; Pei-Yong Shi; Richard Randall; Alexander A Khromykh
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

7.  S-phase-dependent enhancement of dengue virus 2 replication in mosquito cells, but not in human cells.

Authors:  Anna-Marija Helt; Eva Harris
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

8.  Epidemiology of dengue in Sri Lanka before and after the emergence of epidemic dengue hemorrhagic fever.

Authors:  William B Messer; U Tissa Vitarana; Kamalanayani Sivananthan; Jayanthi Elvtigala; L D Preethimala; R Ramesh; Nalini Withana; Duane J Gubler; Aravinda M De Silva
Journal:  Am J Trop Med Hyg       Date:  2002-06       Impact factor: 2.345

9.  High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever.

Authors:  Daniel H Libraty; Paul R Young; Darren Pickering; Timothy P Endy; Siripen Kalayanarooj; Sharone Green; David W Vaughn; Ananda Nisalak; Francis A Ennis; Alan L Rothman
Journal:  J Infect Dis       Date:  2002-09-16       Impact factor: 5.226

10.  A live, attenuated dengue virus type 1 vaccine candidate with a 30-nucleotide deletion in the 3' untranslated region is highly attenuated and immunogenic in monkeys.

Authors:  Stephen S Whitehead; Barry Falgout; Kathryn A Hanley; Joseph E Blaney; Lewis Markoff; Brian R Murphy
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

View more
  44 in total

1.  A lethal murine infection model for dengue virus 3 in AG129 mice deficient in type I and II interferon receptors leads to systemic disease.

Authors:  Vanessa V Sarathy; Mellodee White; Li Li; Summer R Gorder; Richard B Pyles; Gerald A Campbell; Gregg N Milligan; Nigel Bourne; Alan D T Barrett
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  Mutation of Putative N-Glycosylation Sites on Dengue Virus NS4B Decreases RNA Replication.

Authors:  Nenavath Gopal Naik; Huey-Nan Wu
Journal:  J Virol       Date:  2015-04-15       Impact factor: 5.103

3.  A West Nile virus NS4B-P38G mutant strain induces cell intrinsic innate cytokine responses in human monocytic and macrophage cells.

Authors:  Guorui Xie; Huanle Luo; Bing Tian; Brian Mann; Xiaoyong Bao; Jere McBride; Robert Tesh; Alan D Barrett; Tian Wang
Journal:  Vaccine       Date:  2015-01-03       Impact factor: 3.641

4.  Using a Virion Assembly-Defective Dengue Virus as a Vaccine Approach.

Authors:  Chao Shan; Xuping Xie; Jing Zou; Roland Züst; Bo Zhang; Rebecca Ambrose; Jason Mackenzie; Katja Fink; Pei-Yong Shi
Journal:  J Virol       Date:  2018-10-12       Impact factor: 5.103

Review 5.  Mouse models of dengue virus infection for vaccine testing.

Authors:  Vanessa V Sarathy; Gregg N Milligan; Nigel Bourne; Alan D T Barrett
Journal:  Vaccine       Date:  2015-10-23       Impact factor: 3.641

Review 6.  The yellow fever 17D virus as a platform for new live attenuated vaccines.

Authors:  Myrna C Bonaldo; Patrícia C Sequeira; Ricardo Galler
Journal:  Hum Vaccin Immunother       Date:  2014-02-19       Impact factor: 3.452

Review 7.  Novel approaches to flavivirus drug discovery.

Authors:  Carolyn Botting; Richard J Kuhn
Journal:  Expert Opin Drug Discov       Date:  2012-03-22       Impact factor: 6.098

8.  A Combined Genetic-Proteomic Approach Identifies Residues within Dengue Virus NS4B Critical for Interaction with NS3 and Viral Replication.

Authors:  Laurent Chatel-Chaix; Wolfgang Fischl; Pietro Scaturro; Mirko Cortese; Stephanie Kallis; Marie Bartenschlager; Bernd Fischer; Ralf Bartenschlager
Journal:  J Virol       Date:  2015-04-29       Impact factor: 5.103

9.  Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro.

Authors:  John W Schoggins; Marcus Dorner; Michael Feulner; Naoko Imanaka; Mary Y Murphy; Alexander Ploss; Charles M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-20       Impact factor: 11.205

10.  Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines.

Authors:  Roland Züst; Ying-Xiu Toh; Iris Valdés; Daniela Cerny; Julia Heinrich; Lisset Hermida; Ernesto Marcos; Gerardo Guillén; Ulrich Kalinke; Pei-Yong Shi; Katja Fink
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.